Alesha A. Thai

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

J. Mazieres, Alexander Drilon, Amélie Lusque et al. · Annals of Oncology · 2019 · 1.4K citations · Full text

Life Sciences, Immunology, Oncology +17

Prognostic Significance of PD-L1+ and CD8+ Immune Cells in HPV+ Oropharyngeal Squamous Cell Carcinoma

Benjamin Solomon, Richard J. Young, Mathias Bressel et al. · Cancer Immunology Research · 2018 · 127 citations · Full text

Life Sciences, Immunology, Oncology +14

Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis

Danny Rischin, Nikhil I. Khushalani, Chrysalyne D. Schmults et al. · Journal for ImmunoTherapy of Cancer · 2021 · 107 citations · Full text

Medicine, Oncology, Pharmacology +16

Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations (ImmunoTarget).

Julien Mazieres, Alexander Drilon, Laurent Mhanna et al. · Journal of Clinical Oncology · 2018 · 54 citations

Medicine, Immunology, Oncology +17

CAPTEM in Metastatic Well-Differentiated Intermediate to High Grade Neuroendocrine Tumors: A Single Centre Experience

Arvind Sahu, Michael Jefford, Julia Lai‐Kwon et al. · Journal of Oncology · 2019 · 43 citations · Full text

Medicine, Oncology, Pharmacology +17